A股異動 | 岱勒新材升5% 2022年淨利9095.85萬 同比扭虧為盈
格隆匯3月6日丨岱勒新材(300700.SZ)升5.38%,報35.82元,總市值44億元。公司3月3日公佈,2022年實現營業收入6.43億元,同比增長137.42%;淨利潤9095.85萬元,上年同期虧損7812.23萬元;基本每股收益0.77元;擬以資本公積金每10股轉增8股。報吿期內,在全球光伏裝機持續增長的背景下,電鍍金剛石線市場需求旺盛,公司的在手訂單充沛,擴充的產能也得到了穩定釋放,主要產品的銷量較上期實現大幅提升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.